APA (7th ed.) Citation

Jönsson, L., Wimo, A., Handels, R., Johansson, G., Boada, M., Engelborghs, S., . . . Winblad, B. (2023). The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: An EADC-EC viewpoint. The lancet. Regional health, 29, . https://doi.org/10.1016/j.lanepe.2023.100657

Chicago Style (17th ed.) Citation

Jönsson, Linus, et al. "The Affordability of Lecanemab, an Amyloid-targeting Therapy for Alzheimer's Disease: An EADC-EC Viewpoint." The Lancet. Regional Health 29 (2023). https://doi.org/10.1016/j.lanepe.2023.100657.

MLA (9th ed.) Citation

Jönsson, Linus, et al. "The Affordability of Lecanemab, an Amyloid-targeting Therapy for Alzheimer's Disease: An EADC-EC Viewpoint." The Lancet. Regional Health, vol. 29, 2023, https://doi.org/10.1016/j.lanepe.2023.100657.